Učitavanje...
Optimal Bronchodilation for COPD Patients: Are All Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonists the Same?
Bronchodilators provide improvements in lung function and reductions in symptoms and exacerbations, and are the mainstay of pharmacological management of chronic obstructive pulmonary disease (COPD). The Global Initiative for Chronic Obstructive Lung Disease strategy recommends the use of a combinat...
Spremljeno u:
| Izdano u: | Tuberc Respir Dis (Seoul) |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6030660/ https://ncbi.nlm.nih.gov/pubmed/29926556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2018.0040 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|